Ethos and its AI feature offer high-resolution computerised tomography images that help localisation of the target before the treatment
Sir HN Reliance Foundation Hospital introduces ETHOS Linear Accelerator in combination with Surface Guided Radiotherapy.
ETHOS enables a patient-centric approach by providing personalised treatment plans based on each person’s unique anatomy and changes in the tumour on a daily basis. This ability to adapt and adjust the treatment plan throughout the course of therapy ensures precise targeting of the tumour and minimises radiation exposure to healthy tissues.
The technology also adapts to changes in the tumour shape, position, and size during treatment. By accurately tracking and adjusting the treatment beam in real-time, ETHOS maximises the radiation dose to the tumour while minimising damage to surrounding healthy tissues. This ensures optimal treatment, improved outcomes, and reduced side effects.
On the occasion Padmabhushan & Padmashri Dr Suresh Advani, Mentor-Medical Oncology, has quoted “This is India’s First ETHOS Linear Accelerator in combination with Surface Guided Radiotherapy for Cancer Patients and we welcome this remarkable addition to our cancer care at RFH. This innovative technology will help us to treat multiple lesions without any damage to adjacent normal tissue.”
Sharing his thought Dr Prasad Dandekar, Head of Radiation Oncology said, “ETHOS is an Artificial Intelligence based Precision Radiotherapy treatment machine, that will lead to improving cancer outcomes in patients and reduced side effects for the treatment of any kind of cancer.”
Dr Sewanti Limaye, Director-Precision & Medical Oncology, Director – Oncology Research said, “Adaptive radiotherapy with Ethos is AI-based personalised radiation therapy, an exemplar for Precision Radiation and brings about a revolutionary change with it’s new age radiation technique! With Ethos, we look forward to providing highest level of healthcare to our cancer patients at Sir HN Reliance Foundation Hospital”
Dr Vijay Haribhakti, Chair, Onco-sciences, Sir HN Reliance Foundation Hospital said, “Choosing ETHOS is embracing the future of cancer care, where treatments are tailored to an individual’s needs, maximising their chances of a successful outcome and improving the overall quality of life.”
Dr Tarang Gianchandani, Group CEO, Sir HN Reliance Foundation Hospital said, “Adaptive AI based Precision Radiotherapy is the future of radiation therapy, and with ETHOS, we are at the forefront of this revolutionary technology in India.”
Ethos and its AI feature offer high-resolution computerised tomography images that help localisation of the target before the treatment. The equipment has a large treatment bore that alleviates claustrophobia of patients. The wide bore of the Ethos device and the treatment couch that passes the patient through the bore enables patients to feel less claustrophobic. The CBCT feature along with AI ensures that the location of tumor in a patient’s body is accurately mapped and targeted during each therapy.
Ethos does real time optimisations in precisely targeting the tumour and completing each session in much less time. It minimises the damage to healthy organs and tissues located close to the tumor and it decreases side effects.